|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/61 | |
| A61P 7/04 | |||
| A61P 37/06 |
| (11) | Patento numeris | 2991684 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14727380.9 |
| Europos patento paraiškos padavimo data | 2014-04-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/035590 |
| Data | 2014-04-27 |
| (87) | Numeris | WO 2014/179184 |
| Data | 2014-11-06 |
| (30) | Numeris | Data | Šalis |
| 201361816790 P | 2013-04-28 | US |
| (72) |
ASWAD, Fred, Jullien, US
|
| (73) |
Bayer HealthCare LLC,
100 Bayer Boulevard P.O. Box 915, Whippany, NJ 07981,
US
|
| (54) | COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE TO COAGULATION FACTOR PROTEINS |
| COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE TO COAGULATION FACTOR PROTEINS |